3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Sleep Apnea, Obstructive
1
Sleep Apnea Syndromes
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Obesity
1
Breast Neoplasms, Male
1
Interventions
Magnetic Resonance Spectroscopy
4
Therapeutics
3
Immunoenzyme Techniques
3
Early Intervention, Educational
3
Cyclophosphamide
3
Biopsy
3
saponin QA-21V1
2
exemestane
2
Vorinostat
2
Standard of Care
2
Psychiatric Rehabilitation
2
Physical Therapy Modalities
2
Letrozole
2
Immunologic Techniques
2
Gene Expression Profiling
2
Fluorodeoxyglucose F18
2
Flow Cytometry
2
Doxorubicin
2
Docetaxel
2
Chemotherapy, Adjuvant
2
Bevacizumab
2
Anastrozole
2
Acupuncture Therapy
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
pegfilgrastim
1
iso-sulfan blue
1
alovudine
1
Zoledronic Acid
1
Trastuzumab
1
Tomography, Emission-Computed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Breast Neoplasms, Male
×
Testosterone
×
Clear all
NCT05156606
2024-08-09
T&T
University Medical Center Groningen
Phase NA
Terminated
5 enrolled